• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狼疮抗凝物与血栓栓塞:纤维蛋白原、天然抑制剂及血栓形成分子标志物的评估

Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.

作者信息

Gschwandtner M E, Eichinger S, Hütter D, Korninger L, Lechner K, Panzer S, Pabinger I

机构信息

Department of Haematology and Blood Coagulation, University of Vienna, Austria.

出版信息

Blood Coagul Fibrinolysis. 1996 Apr;7(3):325-30.

PMID:8735139
Abstract

It has been speculated that an impairment in anticoagulant pathways (protein C (PC), protein S (PS), resistance to activated protein C (APC)), may contribute to the thrombotic tendency in lupus anticoagulant (LA) patients. Increased plasma levels of fibrinogen are predictive for arterial thrombosis and increased molecular markers of thrombosis are indicative for activation of the clotting cascade. We investigated 25 patients (20 women) with LA. All patients were stratified according to their thromboembolic history and women according to their history of fetal loss. Eighteen patients had a history of venous or arterial thrombosis, or both. Seven of 16 women with at least one pregnancy had a history of fetal loss. The interrelation among the levels of fibrinogen, PC and PS, and resistance to APC, thrombin-antithrombin III complexes (TAT), prothrombin fragment F1 + 2, D-dimer and the history of thrombotic events and obstetric complications in patients with LA were evaluated. LA patients with a history of venous or arterial thrombosis had a significantly higher fibrinogen level than LA patients without (mean 366 versus 304 mg/dl; P = 0.018). Among 16 women a slightly lower mean TAT level in women with fetal loss was found (2.4 versus 4.3 ng/ml; P = 0.02). No other statistically significant difference in the remaining parameters was yielded in both analyzed subgroups. The results of the study suggest an association between increased fibrinogen levels and the history of venous or arterial thrombosis, or both, in patients with LA. In the other investigated parameters, no relationship to the thrombotic or obstetric history was found.

摘要

据推测,抗凝途径(蛋白C(PC)、蛋白S(PS)、对活化蛋白C(APC)的抵抗)受损可能导致狼疮抗凝物(LA)患者的血栓形成倾向。纤维蛋白原血浆水平升高可预测动脉血栓形成,而血栓形成的分子标志物增加则表明凝血级联反应被激活。我们研究了25例LA患者(20例女性)。所有患者根据其血栓栓塞病史进行分层,女性患者根据其流产病史进行分层。18例患者有静脉或动脉血栓形成病史,或两者皆有。16例至少有一次妊娠的女性中有7例有流产病史。评估了LA患者纤维蛋白原、PC和PS水平、对APC的抵抗、凝血酶-抗凝血酶III复合物(TAT)、凝血酶原片段F1 + 2、D-二聚体水平与血栓形成事件和产科并发症病史之间的相互关系。有静脉或动脉血栓形成病史的LA患者纤维蛋白原水平显著高于无此病史的LA患者(平均366对304 mg/dl;P = 0.018)。在16例女性中,发现有流产史的女性平均TAT水平略低(2.4对4.3 ng/ml;P = 0.02)。在两个分析亚组中,其余参数均未产生其他统计学显著差异。研究结果表明,LA患者纤维蛋白原水平升高与静脉或动脉血栓形成病史或两者皆有之间存在关联。在其他研究参数中,未发现与血栓形成或产科病史有关。

相似文献

1
Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.狼疮抗凝物与血栓栓塞:纤维蛋白原、天然抑制剂及血栓形成分子标志物的评估
Blood Coagul Fibrinolysis. 1996 Apr;7(3):325-30.
2
Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.系统性红斑狼疮中的血栓形成事件。其与获得性和遗传性血栓形成倾向缺陷的关联。
Clin Hemorheol Microcirc. 2008;40(2):79-87.
3
Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.系统性红斑狼疮中的血栓形成:先天性和后天性危险因素
Arthritis Rheum. 2005 Jun 15;53(3):452-9. doi: 10.1002/art.21172.
4
Inflammation in patients with lupus anticoagulant and implications for thrombosis.狼疮抗凝物患者的炎症及其与血栓形成的关系
J Rheumatol. 2005 Mar;32(3):462-8.
5
Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
Thromb Haemost. 1996 Aug;76(2):190-4.
6
Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.狼疮抗凝物与血栓形成:不同凝血及免疫学检测的临床关联
Thromb Haemost. 2000 Dec;84(6):1012-6.
7
Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.希腊炎症性肠病患者对活化蛋白C的抵抗及游离蛋白S水平降低
Am J Gastroenterol. 2000 Jan;95(1):190-4. doi: 10.1111/j.1572-0241.2000.01683.x.
8
Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?患有易栓症且既往有静脉血栓栓塞症的患者发生动脉血栓形成的风险更高吗?
Thromb Res. 2008;121(6):743-50. doi: 10.1016/j.thromres.2007.07.014. Epub 2007 Sep 4.
9
Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant.
J Lab Clin Med. 1995 Jan;125(1):56-65.
10
[Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].121例静脉或动脉血栓形成患者的抗凝血酶III、蛋白C、蛋白S和因子XII遗传性缺乏症
Srp Arh Celok Lek. 1999 Jan-Feb;127(1-2):21-7.